selected publications
-
academic article
- Population Pharmacokinetic Model of Adalimumab Based on Prior Information Using Real World Data. BIOMEDICINES. 2822-2834. 2023
- Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review. PHARMACEUTICS. 1009-1027. 2022
- Evaluation of the Predictive Performance of Population Pharmacokinetic Models of Adalimumab in Patients with Inflammatory Bowel Disease. PHARMACEUTICS. 1244-1257. 2021
- Modelos farmacocinéticos poblacionales de sirólimus en pacientes trasplantados renales: Revisión sistemática. FARMACIA HOSPITALARIA. 77-83. 2021
-
congress communication
- Evaluación de seis modelos farmacocinéticos poblacionales de adalimumab en pacientes con enfermedad inflamatoria intestinal 2022
- POPULATION PHARMACOKINETIC MODEL ADAPTED OF ADALIMUMAB FOR INFLAMMATORY BOWEL DISEASE 2022
- Validation of a population pharmacokinetic model of vedolizumab: application in clinical practice 2021
- EVALUATION OF THE PREDICTIVE PERFORMANCE OF TWO POPULATION PHARMACOKINETIC MODELS OF VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE 2020